ES2093717T3 - Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo. - Google Patents

Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo.

Info

Publication number
ES2093717T3
ES2093717T3 ES91919149T ES91919149T ES2093717T3 ES 2093717 T3 ES2093717 T3 ES 2093717T3 ES 91919149 T ES91919149 T ES 91919149T ES 91919149 T ES91919149 T ES 91919149T ES 2093717 T3 ES2093717 T3 ES 2093717T3
Authority
ES
Spain
Prior art keywords
hirudine
production
vector
sequence
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919149T
Other languages
English (en)
Inventor
Satoru Misawa
Hitoshi Matsuda
Yoshifumi Inoue
Hideyuki Furuya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2303096A external-priority patent/JPH07119237B2/ja
Priority claimed from JP4127191A external-priority patent/JP3226289B2/ja
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Application granted granted Critical
Publication of ES2093717T3 publication Critical patent/ES2093717T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN MUTANTE HIRUDINO HVIC3, PREPARADO SUBSTITUYENDO UNA SECUENCIA DE AMINOACIDOS, QUE EMPIEZA CON EL AMINOACIDO 53, RESIDUO DEL HIRUDINO HV1, POR OTRA SECUENCIA DE AMINOACIDOS QUE EMPIEZA CON EL AMINOACIDO 53, RESIDUO DEL HIRUDINO HV3. DICHO MUTANTE NO SOLO TIENE UN ALTO EFECTO ANTITROMBO SINO QUE TAMBIEN SIRVE PARA INHIBIR EL ALARGAMIENTO DEL TIEMPO DE SANGRADO. ESCHERICHIA COLI TRANSFORMADA POR UN VECTOR SEGREGANTE DE PROTEINA EXTRAÑA, COMPRENDIENDO UNA SECUENCIA DE ADN QUE CONTIENE UN ORIGEN (ORI) DE PLASMIDO PUC, UNA SECUENCIA ADN DE PROMOTOR TAC O PROMOTOR TRP, UNA SECUENCIA ADN CODIFICADA COMO PEPTIDO DE SEÑAL Y UNA SECUENCIA ADN CODIFICADA COMO PROTEINA EXTRAÑA, QUE SEGREGA Y PRODUCE PROTEINAS EXTRAÑAS EN GRANDES CANTIDADES FUERA DE LAS CELULAS.
ES91919149T 1990-11-08 1991-11-08 Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo. Expired - Lifetime ES2093717T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2303096A JPH07119237B2 (ja) 1990-11-08 1990-11-08 ヒルジン変異体，その製造法及び抗凝血剤
JP4127191A JP3226289B2 (ja) 1991-02-13 1991-02-13 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法

Publications (1)

Publication Number Publication Date
ES2093717T3 true ES2093717T3 (es) 1997-01-01

Family

ID=26380836

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91919149T Expired - Lifetime ES2093717T3 (es) 1990-11-08 1991-11-08 Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo.
ES95202092T Expired - Lifetime ES2129749T3 (es) 1990-11-08 1991-11-08 Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95202092T Expired - Lifetime ES2129749T3 (es) 1990-11-08 1991-11-08 Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo.

Country Status (12)

Country Link
US (2) US5516656A (es)
EP (2) EP0511393B1 (es)
AT (2) ATE176500T1 (es)
AU (2) AU648124B2 (es)
CA (2) CA2072375C (es)
DE (2) DE69130872T2 (es)
DK (2) DK0511393T3 (es)
ES (2) ES2093717T3 (es)
FI (1) FI107928B (es)
GR (2) GR3021410T3 (es)
NO (2) NO303735B1 (es)
WO (1) WO1992008736A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
CA2205356A1 (en) * 1994-11-21 1996-05-30 Peter Edward Urwin Modified proteinase inhibitors
DE19944870A1 (de) * 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108212A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
DE10108211A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
CA2496990A1 (en) * 2002-08-23 2004-03-04 E.I. Du Pont De Nemours And Company Utilization of starch products for biological production by fermentation
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
EP1903115B1 (de) * 2006-09-22 2011-03-09 Wacker Chemie AG Verfahren zur fermentativen Herstellung von Antikörpern
CN101372512B (zh) * 2007-08-23 2011-03-23 中国人民解放军军事医学科学院生物工程研究所 一类抗凝血多肽及其用途
WO2010054503A1 (zh) * 2008-11-17 2010-05-20 中国人民解放军军事医学科学院生物工程研究所 抗凝血多肽及其应用
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562088B1 (fr) * 1984-03-27 1987-11-13 Transgene Sa Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0177343B1 (en) * 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
JP2518862B2 (ja) * 1987-08-31 1996-07-31 株式会社蛋白工学研究所 新規プラスミドベクタ―
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
AU614121B2 (en) 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
JPH0648988B2 (ja) 1988-07-26 1994-06-29 工業技術院長 トロンビン阻害物質の製造法
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JPH0292288A (ja) * 1988-09-30 1990-04-03 Japan Tobacco Inc アクアライシンｉ前駆体をコードする遺伝子、それを含む発現ベクター、該発現ベクターを含む大腸菌及びそれを用いたアクアライシンｉの製造方法
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
IE902877A1 (en) * 1989-08-10 1991-02-27 Japan Energy Corp Expression vector for hirudin, hirudin fusion protein,¹transformed microorganism and method for production of¹hirudin
JPH03164184A (ja) 1989-08-10 1991-07-16 Nippon Mining Co Ltd ヒルジン発現ベクター、ヒルジン融合蛋白、形質転換微生物及びヒルジンの製造法
JPH0376579A (ja) 1989-08-18 1991-04-02 Nippon Mining Co Ltd ヒト‐アンジオジェニン発現ベクター及びヒト‐アンジオジェニンの製造方法
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins

Also Published As

Publication number Publication date
AU648124B2 (en) 1994-04-14
AU673870B2 (en) 1996-11-28
DE69121192T2 (de) 1997-02-20
WO1992008736A1 (en) 1992-05-29
FI922963A0 (fi) 1992-06-26
EP0687731A1 (en) 1995-12-20
GR3021410T3 (en) 1997-01-31
GR3029824T3 (en) 1999-06-30
AU5470194A (en) 1994-03-24
NO982207D0 (no) 1998-05-14
NO922671D0 (no) 1992-07-07
EP0687731B1 (en) 1999-02-03
DK0511393T3 (da) 1996-12-09
CA2072375C (en) 2000-01-11
ATE140929T1 (de) 1996-08-15
DK0687731T3 (da) 1999-09-20
EP0511393A1 (en) 1992-11-04
AU8846691A (en) 1992-06-11
ATE176500T1 (de) 1999-02-15
NO982207L (no) 1992-09-07
CA2072375A1 (en) 1992-05-09
DE69121192D1 (de) 1996-09-05
FI922963L (fi) 1992-06-26
NO303735B1 (no) 1998-08-24
DE69130872D1 (de) 1999-03-18
US5516656A (en) 1996-05-14
ES2129749T3 (es) 1999-06-16
CA2255396A1 (en) 1992-05-09
US5573929A (en) 1996-11-12
EP0511393B1 (en) 1996-07-31
NO922671L (no) 1992-09-07
FI107928B (fi) 2001-10-31
DE69130872T2 (de) 1999-08-26
EP0511393A4 (en) 1993-08-11

Similar Documents

Publication Publication Date Title
ES2093717T3 (es) Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo.
AU1672388A (en) Expression of human proapolipoprotein a-i
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
HUP9900878A2 (hu) Alfa-hordotionin nagy metionintartalmú származéka
NO913232L (no) Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.
ATE280234T1 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
ES2137182T3 (es) Derivados recombinantes del factor viii humano.
ES8800276A1 (es) Un procedimiento para preparar nuevos derivados de insulina
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
HUP9900876A2 (hu) Az alfa-hordotionin nagy treonintartalmú származékai
ES2150916T3 (es) Utilizacion del acido gentisico o del alcohol gentisilico para estabilizar peptidos y proteinas radiomarcados.
AR016537A1 (es) Una celula humana para la fabricacion de eritropoyetina por activacion genica endogena, un procedimiento para la fabricacion de la misma y una construccionde adn a ser usada en el mismo, un procedimiento para la fabricacion de epo humana, epo humana aislada obtenida por el mismo y un preparado farma
DE3650788D1 (de) Produktion des pluripotenten Granulozyten-Koloniestimulierungsfaktors
YU53290A (sh) Postupak za dobijanje novih jedinjenja insulina
ES8601109A1 (es) Procedimiento para preparar suspensiones de cristales de uno o mas derivados de insulina
IL85020A (en) Pancreatic secretory trypsin inhibitor variants, their production, expression vectors and recombinant hosts therefor and pharmaceutical compositions containing them
IL96368A0 (en) Protein complexes having factor viii:c activity,their production,and pharmaceutical compositions containing them
KR870004139A (ko) 인체 λ-인터페론의 생물학적 활성 유도체를 제조하는 방법
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
KR850001775A (ko) 인슐린 유도체의 제조방법
AU5008785A (en) Process for synthesising peptides
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
Somerville Tryptophan: Biosynthesis, regulation, and large-scale production.
ES8707554A1 (es) Procedimiento para preparar interferon-a recombinante

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 511393

Country of ref document: ES